Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,918 papers from all fields of science
Search
Sign In
Create Free Account
U 77779
Known as:
U-77,779
, U-77779
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
bizelesin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
DNA Damage and Differential Cytotoxicity Produced in Human Carcinoma Cells by CC-1065 Analogues , U-73 , 975 and U-77 , 7791
Chong-soon Lee
,
N. Gibson
2006
Corpus ID: 15066679
U-73,975 (U-73) and U-77,779 (U-77), two analogues of the cyclopropylpyrroloindole ant ¡iuniorantibiotic CC-1065, are promising…
Expand
2001
2001
Novel seco cyclopropa[c]pyrrolo[3,2-e]indole bisalkylators bearing a 3,3'-arylenebisacryloyl group as a linker.
Y. Fukuda
,
S. Seto
,
H. Furuta
,
H. Ebisu
,
Y. Oomori
,
S. Terashima
Journal of Medicinal Chemistry
2001
Corpus ID: 24432577
We synthesized the novel seco cyclopropa[c]pyrrolo[3,2-e]indole (CPI) bisalkylators and evaluated their antitumor activity. Among…
Expand
1998
1998
The novel cyclopropapyrroloindole(CPI) bisalkylators bearing 3,3'-(1,4-phenylene)diacryloyl group as a linker.
Y. Fukuda
,
S. Seto
,
H. Furuta
,
H. Ebisu
,
Y. Oomori
,
S. Terashima
Bioorganic & Medicinal Chemistry Letters
1998
Corpus ID: 2946330
1993
1993
Nucleotide preferences for DNA interstrand cross-linking induced by the cyclopropylpyrroloindole analogue U-77,779.
Chong Soon Lee
,
Neil W. Gibson
Biochemistry
1993
Corpus ID: 41380795
Using a 21-base-pair duplex oligonucleotide containing a centrally located defined cross-linkable site, we have separated by gel…
Expand
1992
1992
Resistance of CHO cells expressing P-glycoprotein to cyclopropylpyrroloindole (CPI) alkylating agents.
T. J. Zsido
,
T. Beerman
,
R. L. Meegan
,
J. Woynarowski
,
R. Baker
Biochemical Pharmacology
1992
Corpus ID: 12061827
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE